Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Blood
; 139(6): 942-946, 2022 02 10.
Article
in En
| MEDLINE
| ID: mdl-34905598
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
ADP-ribosyl Cyclase 1
/
Antineoplastic Agents, Immunological
/
SARS-CoV-2
/
COVID-19
/
BNT162 Vaccine
/
Multiple Myeloma
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2022
Document type:
Article
Country of publication: